Preview

Current Pediatrics

Advanced search

DETERMINATION OF QUANTITATIVE LEVEL OF PROCALCITONIN AND ESTIMATION OF ITS DYNAMICS IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS

Abstract

Questions of differential diagnosis in conditions of developed systemic inflammatory reaction in patients with systemic type of juvenile rheumatoid arthritis (JRA) are one of difficult problems in children's rheumatology. Clinical signs, similar to sepsis, accompanied by development of symptoms of inflammatory reaction may be observed in patients with systemic type of JRA at the time of exacerbation of main disease, or due to development of bacterial complications and medicinal reactions, or it may be the consequence of combination of these reasons. Presented case report allows making a conclusion that using of procalcitonin test, especially quantitative one, in usual practice of rheuma tologist permits to carry out a differential diagnosis between infectious and autoimmune reasons of developed systemic inflammatory reaction, to start an etiotropiс and/or pathogenetic treatment at the proper time, to estimate the severity of pathological process and activity of therapy in first days from its onset, and to determine an optimal duration of treatment.
Key words: juvenile rheumatoid arthritis, procalcitonine test, differential diagnosis.

About the Authors

A.M. Chomakhidze
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


E.I. Alexeeva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


S.I. Valieva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


T.M. Bzarova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


R.V. Denisova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


References

1. Баранов А.А. Ревматические болезни у детей: проблемы и пути их решения. Вопросы современной педиатрии. 2004; 3 (1): 7–11.

2. Deborah P.M., Symmons. XIV EULAR Congr.Rheumatol. Glasgow. June 6–11, 1999. Abstracts 1. Р. 1.

3. Логинова Е.Ю. Взгляд ревматолога интерниста на терминологию классификацию и нозологическую диагностику ювенильного артрита. Научно-практическая ревматология. 2001; 2: 21–30.

4. Насонов Е.Л. Ревматоидный артрит, терапевтические проблемы. Врач. 1999; 5: 7–11.

5. Вест С.Д. Секреты ревматологии. М. 1999. 768с.

6. Gilliand W.R. Prophylactic use of antibiotics and immunization in patient with SLE. Ann. of the Rheum. Dis. 2002; 61: 623–625.

7. Bone R.C., Balk R.A., Cerra F.B. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies is sepsis. The ACCP/SCCM Consensus Conference Committee American College of Chest Physicians. Society of Critical Care Medicine. Chest. 1992; 101 (6): 1644–1655.

8. Gramm H.J., Hannemann L., Reinhart K. Sepsis: a conception in change. Possibilities and limitation of diagnosis based on clinical criteria. Dtsch. Med. Wochenschr.1995; 120 (14): 498–502.

9. Rangel-Frausto M.S., Pitter D., Costigan M. et al. The natural history of the systemic in inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995; 273 (2): 117–123.

10. Baquero F., Fernandes-Jorge A., Vicente M.F. et al. Diversity analysis of the human faecal flora: a simple method of based on bacterial morph types. Microb. Ecol. Heals Dis. 1998; 1 (1): 101–108

11. Гельфанд Б.Р, Филимонов М.И., Бражник Т.Б., Сергеева Н.А., Бурневич С.З. Прокальцитонин: новый лабораторный диагностический маркер сепсиса и гнойно–септических осложнений в хирургии. Вестник интенсивной терапии. 2003; 1 (2).

12. Клиническое применение прокальцитонина для диагностики и мониторинга скепсиса. Руководство. 2004. 24 с.

13. Korcsowski B., Kovalczyk J.R., Biiark M. Concentration of procalcitonin and C-reactive protein in serum and erythrocyte sedimentation rate in active autoimmune disease in children. Pol. Merkur. Lecarski. 2003; 15 (86): 155–157.

14. Белобородова Н.В., Попов Д.А., Шаталов К.В. Заместительная иммунотерапия под контролем теста на прокальцитонин. В кн.: Бактериальные инфекции в стационаре:поиск новых решений. Под ред. Белобородовой. М.: НЦСХХ им. А.Н. Бакулева. 2005. С.138–144.

15. Чомахидзе А.М, Алексеева Е.И. Прокальцитониновый тест в дифференциальной диагностике синдрома аллергосепсиса. Вопросы современной педиатрии. 2007; 6 (2): 42–47.


Review

For citations:


Chomakhidze A., Alexeeva E., Valieva S., Bzarova T., Denisova R. DETERMINATION OF QUANTITATIVE LEVEL OF PROCALCITONIN AND ESTIMATION OF ITS DYNAMICS IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS. Current Pediatrics. 2008;7(6):167-172.

Views: 577


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)